CV DISEASE
Results overall provide more definitive evidence that testosterone therapy (when performed appropriately) does not increase the risk for major CV events after a mean 2 years of treatment. The secondary findings of increased arrhythmias, atrial fibrillation, and minimally elevated...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.